[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Lee et al., 2018 - Google Patents

Synthetic lethal and convergent biological effects of cancer-associated spliceosomal gene mutations

Lee et al., 2018

View HTML @Full View
Document ID
12316009228278738899
Author
Lee S
North K
Kim E
Jang E
Obeng E
Lu S
Liu B
Inoue D
Yoshimi A
Ki M
Yeo M
Zhang X
Kim M
Cho H
Chung Y
Taylor J
Durham B
Kim Y
Pastore A
Monette S
Palacino J
Seiler M
Buonamici S
Smith P
Ebert B
Bradley R
Abdel-Wahab O
Publication year
Publication venue
Cancer cell

External Links

Snippet

Mutations affecting RNA splicing factors are the most common genetic alterations in myelodysplastic syndrome (MDS) patients and occur in a mutually exclusive manner. The basis for the mutual exclusivity of these mutations and how they contribute to MDS is not well …
Continue reading at www.cell.com (HTML) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Similar Documents

Publication Publication Date Title
Lee et al. Synthetic lethal and convergent biological effects of cancer-associated spliceosomal gene mutations
Samarasinghe et al. Targeted degradation of transcription factors by TRAFTACs: transcription factor targeting chimeras
Dingler et al. Two aldehyde clearance systems are essential to prevent lethal formaldehyde accumulation in mice and humans
Wang et al. Targeting an RNA-binding protein network in acute myeloid leukemia
Volk et al. A CHAF1B-dependent molecular switch in hematopoiesis and leukemia pathogenesis
Kim et al. SRSF2 mutations contribute to myelodysplasia by mutant-specific effects on exon recognition
Brunetti et al. Mutant NPM1 maintains the leukemic state through HOX expression
Xiao et al. B-cell-specific diversion of glucose carbon utilization reveals a unique vulnerability in B cell malignancies
Cimmino et al. Restoration of TET2 function blocks aberrant self-renewal and leukemia progression
Ma et al. APOL1 renal-risk variants induce mitochondrial dysfunction
Qi et al. HDAC8 inhibition specifically targets Inv (16) acute myeloid leukemic stem cells by restoring p53 acetylation
Colla et al. Telomere dysfunction drives aberrant hematopoietic differentiation and myelodysplastic syndrome
Li et al. Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence
Nagamachi et al. Haploinsufficiency of SAMD9L, an endosome fusion facilitator, causes myeloid malignancies in mice mimicking human diseases with monosomy 7
Biddle et al. Phenotypic plasticity determines cancer stem cell therapeutic resistance in oral squamous cell carcinoma
Abdel-Wahab et al. ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression
Pignatti et al. Beta-catenin causes adrenal hyperplasia by blocking zonal transdifferentiation
Cole et al. Histone H2B monoubiquitination: roles to play in human malignancy
Rathinam et al. Myeloid leukemia development in c-Cbl RING finger mutant mice is dependent on FLT3 signaling
Gu et al. Discovery of dual inhibitors of MDM2 and XIAP for cancer treatment
Wakabayashi et al. Impaired KLHL3-mediated ubiquitination of WNK4 causes human hypertension
Sanz et al. Cell-type-specific isolation of ribosome-associated mRNA from complex tissues
Vasileiou et al. Chromatin-remodeling-factor ARID1B represses Wnt/β-catenin signaling
Tollini et al. Regulation of p53 by Mdm2 E3 ligase function is dispensable in embryogenesis and development, but essential in response to DNA damage
Sondalle et al. Fanconi anemia protein FANCI functions in ribosome biogenesis